SEC Form 4 · accession 0001591408-16-000012
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD · M??????
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eisaku Nakamura
Director
Period of report
Jan 18, 2016
Accepted (ET)
Jan 19, 2016 · 8:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001400482
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1,F3,F4 | $9.06 | Jan 18, 2016 | A | 30,000 | A | — | Jan 15, 2026 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The exercise price of the stock options is the closing price of the Issuer's common stock on January 18, 2016 which is the first trading day of the Issuer's common stock on the Tokyo Stock Exchange following the January 15, 2016 grant date.
- F2The options were deemed to be acquired by the Reporting Person upon the date the exercise price became fixed.
- F3The options vest on a monthly pro rata basis over a four (4) year period that commenced on May 1, 2015 and will continue until May 1, 2019, at which time all of the options will be fully vested.
- F4The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the Issuer's registration statement on Form S-1 (File No. 333-192900)